MEGDEL Syndrome: Expanding the Phenotype and New Mutations

Abstract

3-MEthylGlutaconic aciduria, Deafness, Encephalopathy, neuroradiological evidence of Leigh-like disease (MEGDEL syndrome) was initially described in four children with additional features of defective oxidative phosphorylation. Loss of functional variants in the SERAC1 gene was later reported in relation with this disorder of phospholipid remodeling. We describe a girl born after a pregnancy complicated by intrauterine growth retardation. In the neonatal period, she presented hypotonia, lethargy, weak reflexes, transient hypoglycemia, and elevated transaminases. Magnetic resonance imaging (MRI) performed at 12 days of life showed bilateral basal ganglia alterations suggestive of Leigh syndrome. She progressed with failure to thrive, severe delay of developmental milestones, axial hypotonia, spastic tetraparesis and dystonic movements. Investigations disclosed hyperlactacidemia, and the urinary organic acids revealed high levels mainly of 3-methylglutaconic acid. Muscle biopsy showed decreased activity of several complexes of the respiratory chain. Compound heterozygosity for two previously unreported variants in SERAC1 leads to the diagnosis of MEGDEL syndrome. Unlike other patients, this child presents very early MRI alterations and manifests no deafness.

Keywords

MEGDEL syndrome - SERAC1 gene - 3-methylglutaconic aciduria - mitochondrial disorder - Leigh syndrome

• References

• 1 Wortmann SB, Duran M, Anikster Y. , et al. Inborn errors of metabolism with 3-methylglutaconic aciduria as discriminative feature: proper classification and nomenclature. J Inherit Metab Dis 2013; 36 (06) 923-928
• 2 Wortmann S, Rodenburg RJ, Huizing M. , et al. Association of 3-methylglutaconic aciduria with sensori-neural deafness, encephalopathy, and Leigh-like syndrome (MEGDEL association) in four patients with a disorder of the oxidative phosphorylation. Mol Genet Metab 2006; 88 (01) 47-52
• 3 Wortmann SB, Vaz FM, Gardeitchik T. , et al. Mutations in the phospholipid remodeling gene SERAC1 impair mitochondrial function and intracellular cholesterol trafficking and cause dystonia and deafness. Nat Genet 2012; 44 (07) 797-802
• 4 Mandel H, Saita S, Edvardson S. , et al. Deficiency of HTRA2/Omi is associated with infantile neurodegeneration and 3-methylglutaconic aciduria. J Med Genet 2016; 53 (10) 690-696
• 5 Oláhová M, Thompson K, Hardy SA. , et al. Pathogenic variants in HTRA2 cause an early-onset mitochondrial syndrome associated with 3-methylglutaconic aciduria. J Inherit Metab Dis 2017; 40 (01) 121-130
• 6 Tort F, García-Silva MT, Ferrer-Cortès X. , et al. Exome sequencing identifies a new mutation in SERAC1 in a patient with 3-methylglutaconic aciduria. Mol Genet Metab 2013; 110 (1-2): 73-77
• 7 Lumish HS, Yang Y, Xia F, Wilson A, Chung WK. The expanding MEGDEL phenotype: optic nerve atrophy, microcephaly, and myoclonic epilepsy in a child with SERAC1 mutations. JIMD Rep 2014; 16: 75-79
• 8 Rodríguez-García ME, Martín-Hernández E, de Aragón AM. , et al. First missense mutation outside of SERAC1 lipase domain affecting intracellular cholesterol trafficking. Neurogenetics 2016; 17 (01) 51-56
• 9 Wortmann SB, Kluijtmans LAJ, Sequeira S, Wevers RA, Morava E. Leucine loading test is only discriminative for 3-methylglutaconic aciduria due to AUH defect. JIMD Rep 2014; 16: 1-6
• 10 Karkucinska-Wieckowska A, Lebiedzinska M, Jurkiewicz E. , et al. Increased reactive oxygen species (ROS) production and low catalase level in fibroblasts of a girl with MEGDEL association (Leigh syndrome, deafness, 3-methylglutaconic aciduria). Folia Neuropathol 2011; 49 (01) 56-63
• 11 Sarig O, Goldsher D, Nousbeck J. , et al. Infantile mitochondrial hepatopathy is a cardinal feature of MEGDEL syndrome (3-methylglutaconic aciduria type IV with sensorineural deafness, encephalopathy and Leigh-like syndrome) caused by novel mutations in SERAC1. Am J Med Genet A 2013; 161A [phone]
• 12 Wortmann SB, van Hasselt PM, Barić I. , et al. Eyes on MEGDEL: distinctive basal ganglia involvement in dystonia deafness syndrome. Neuropediatrics 2015; 46 (02) 98-103